ClinicalTrials.gg
RecruitingNCT07442747Updated Oct 26, 2026

Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS

A Phase 2 interventional study of Exercise in Parkinson's Disease and Deep Brain Stimulation, sponsored by The Cleveland Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by The Cleveland Clinic · Phase 2, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Oct 26, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Parkinson Disease by The Cleveland Clinic — 5 open to participants now, 5 under way, none of them phase 3. Parkinson Disease · The Cleveland Clinic.

Planned enrollment
8th of 14
36 · median 38
Started
2026
with 2 others
Phase 2
2 of 15
1 open now
Registered
13th of 15
by date

Among the 15 studies in Parkinson Disease by The Cleveland Clinic, this one is the 8th largest by planned enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2026, is one of 2 in phase 2, and was the 13th registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

5 of the 15 studies in Parkinson Disease by The Cleveland Clinic are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Parkinson Disease by The Cleveland Clinic, or all of them as a file.
02

Study summary

This study is focused on people with Parkinson's disease who already have deep brain stimulation devices. The goal is to understand how aerobic exercise, specifically forced vs voluntary cycling, affects movement, thinking, and brain activity in these individuals. Parkinson's disease is a progressive condition that impacts both movement and cognitive function. Previous research suggests aerobic exercise can improve PD symptoms, but the mechanisms underlying the improvement are not fully understood. This study aims to evaluate the neural (brain) mechanisms underlying exercise.

Read the detailed description

This study is investigating how aerobic exercise, specifically forced exercise (FE) and voluntary exercise (VE), affects movement, thinking, and brain activity in people with advanced Parkinson's disease who have deep brain stimulation (DBS). Over eight weeks, 36 participants will complete either a forced cycling program (where a motor helps them pedal faster than they could on their own) or a voluntary cycling program at a self-driven pace. Participants will complete an 8-week delayed start period to serve as a comparison before starting an exercise program.

The study will measure motor symptoms, cognitive performance, and brain activity from both the cortex (via EEG) and the subthalamic nucleus (via DBS device recordings) at several time points, including before treatment, after the 8-week exercise period, and again four weeks later. By analyzing how neural signals change at rest and during tasks, the study will evaluate the neural mechanisms that make exercise beneficial. This research could ultimately guide more effective, personalized exercise therapies to support people with advanced Parkinson's disease with DBS.

03

Conditions studied

  • Parkinson's Disease
  • Deep Brain Stimulation

Keywords

  • Parkinson
  • Deep Brain Stimulation
  • Parkinson's disease
  • Deep Brain Stimulation Surgery
  • DBS
  • Exercise
  • exercise training
  • Parkinson disease
  • Parkinson's
  • Parkinson's Disease with Deep Brain Stimulation
  • Percept
  • Cycling
  • Aerobic
04

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Parkinson's disease
  • Previous placement of bilateral Medtronic Percept DBS as standard of care treatment for PD
  • Clinically optimized DBS parameters for one month prior to enrollment
  • Ability to ambulate with or without an assistive device for 5 continuous minutes
  • Willingness to withhold antiparkinsonian medication and DBS stimulation for outcomes assessments
  • Medical clearance for moderate-high intensity exercise given by treating physician or physician extender

Exclusion criteria

Exclusion Criteria:

  • Neurocognitive impairment that compromises the ability to provide
  • Neurological disease other than Parkinson's disease (i.e. multiple sclerosis, stroke)
  • A musculoskeletal issue (arthritis, osteoporosis, back problem) that would limit one's ability to engage in exercise
  • Current cardiac arrhythmia
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Forced Exercise (FE)

    Participants in the forced exercise group will complete an eight-week control period where they will be asked to maintain their usual activities and wear an activity monitoring device. This will be followed by an eight-week cycling program using a stationary bike equipped with a motor that assists pedaling. The motor helps maintain a cadence higher than the participant's voluntary pace, typically around 80-90 revolutions per minute, while the participant continues to actively pedal. Each session lasts about 40 minutes and occurs three times per week under supervision of an exercise professional. Heart rate will be monitored to ensure safety and maintain aerobic intensity. The goal is to provide consistent, high-rate cycling that participants likely could not achieve on their own.

    Behavioral: Exercise

  • Experimental
    Voluntary Exercise (VE)

    Participants in the voluntary exercise group will complete an eight-week control period where they will be asked to maintain their usual activities and wear an activity monitoring device. This will be followed by an eight-week cycling program on a standard stationary bike. They will cycle at a self-selected pace while maintaining a target heart rate to ensure aerobic intensity. Each session lasts about 40 minutes and occurs three times per week under supervision of an exercise professional. Heart rate will be monitored for safety and consistency.

    Behavioral: Exercise

Interventions

  • BehavioralExercise

    Participants will complete an eight-week control period followed by an eight-week cycling program. They will complete 3 sessions per week in-person with a member of the study team, for a total of 24 exercise sessions.

06

What researchers measure

Primary outcomes

  1. Movement Disorder Society-Unified Parkinson's Disease Rating Scale (Motor Examination)

    Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III: Motor Examination score, measured off medication. Range of scores is 0 to 132, with lower score indicating better motor function. Change in MDS-UPDRS III score from baseline to end-of-treatment (EOT) and baseline to EOT+4 weeks.

    Time frame: Baseline to EOT and Baseline to EOT+4 weeks

  2. Relative Root Mean Square Error of a Grip Force Tracking Task

    Participants are required to modulate the precision grip force of their dominant hand to match a target trajectory on a computer screen. Relative root mean squared error quantifies deviation from the target force trajectory. Values are normalized for maximum target amplitude, with lower values indicating decreased error.

    Time frame: Baseline to EOT and Baseline to EOT+4 weeks

  3. Local Field Potential Subthalamic Nucleus Beta at Rest

    Normalized beta band activity is reported as the change in resting-state STN beta band (13-30Hz) power. Higher beta band suggests increased pathological electrical synchrony.

    Time frame: Baseline to EOT and Baseline to EOT+4 weeks

07

Study locations

1 of 1 sites recruiting
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
    Recruiting
    • MacKenzie Dunlap · Contactdunlapm4@ccf.org · 216-219-3949
    • Jay L Alberts, PhD · Principal investigator
    • Anson Rosenfeldt, PT, DPT, MBA · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Dec 2029, 41 months after the start.

Of 106 non-industry phase 2 interventional studies under Parkinson Disease, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 59. This study's planned 41 months is above that.

Counting every sponsor, half of 203 studies reached it within 28 months; a quarter within 16 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2026
First posted
Mar 2, 2026
StartActual
Jul 8, 2026
Primary completionEst.
Dec 31, 2029
CompletionEst.
Dec 31, 2029
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion added; 3 exclusion criteria removed
What changed in the criteria
Inclusion criteria
  • AddedMedical clearance for moderate-high intensity exercise given by treating physician or physician extender
Exclusion criteria
  • RemovedRecommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen:
  • RemovedIf the ACSM screen recommends medical clearance, the subject must obtain medical clearance by their health care provided prior to participation.
  • RemovedThose who choose not to obtain physician clearance will not be eligible for participation. Those who do not receive physician clearance for high intensity exercise will not be eligible.
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Eligibility 1 inclusion criterion added; 3 exclusion criteria removed
    What changed in the criteria
    Inclusion criteria
    • AddedMedical clearance for moderate-high intensity exercise given by treating physician or physician extender
    Exclusion criteria
    • RemovedRecommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen:
    • RemovedIf the ACSM screen recommends medical clearance, the subject must obtain medical clearance by their health care provided prior to participation.
    • RemovedThose who choose not to obtain physician clearance will not be eligible for participation. Those who do not receive physician clearance for high intensity exercise will not be eligible.
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07442747
Responsible party
Jay Alberts (Staff, The Cleveland Clinic) — Principal investigator
First posted
Mar 2, 2026
Start date
Jul 8, 2026
Primary completion
Dec 31, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Oct 26, 2026

Study contacts

MacKenzie Dunlap
Contact
dunlapm4@ccf.org
216-219-3949
Jay L Alberts, PhD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion